EHRA Premium Access

Panel discussion

Congress Presentation

4 more presentations in this session

Next generation drugs for atrial fibrillation in humans - Good new chemistry

Speaker: Professor D. Dobrev (Essen, DE)


Molecular therapy for genetic arrhythmogenic diseases - A white coats' tandem

Speaker: Professor S. Priori (Pavia, IT)


Biological shockless defibrillation - True translational challenges

Speaker: Professor D. Pijnappels (Leiden, NL)


Low voltage electrotherapy for atrial arrhythmias - First-in-human

Speaker: Professor I. Efimov (Chicago, US)


Access the full session

Exploration of novel anti-fibrillatory strategies - A joint PhD-MD effort

Speakers: Professor D. Dobrev, Professor S. Priori, Professor D. Pijnappels, Professor I. Efimov

About the event


EHRA 2019

17 March - 19 March 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb